abstract |
The present patent application discloses at least the compounds according to Formula (Ia) and Formula (Ib) shown below, or pharmaceutically acceptable salts thereof, wherein ring D, ring A, J B , n, J, R C1 , R C2 , Z 1 , Z 2 , W, X, Y 1 , Y2, J F and R 9 are as defined herein. |